CXL Outcomes Consistent Across Populations
Ethnicity and age show limited impact on cross-linking outcomes for keratoconus
Clinical Scorecard: CXL Outcomes Consistent Across Populations
At a Glance
Category Detail
Condition Keratoconus Key Mechanisms Corneal cross-linking (CXL) to stabilize or improve corneal curvature and thickness. Target Population Patients with keratoconus across different ethnic groups and age ranges. Care Setting Clinical settings offering epithelium-off accelerated CXL.
Key Highlights
CXL effective across UK and Saudi populations despite baseline severity differences. Over 80% of eyes stabilized or improved post-CXL at three years. Mean Kmax improved significantly in both cohorts. No significant age-dependent treatment effects observed. Baseline disease severity is a key factor influencing treatment outcomes. Guideline-Based Recommendations
Diagnosis
Assess keratoconus severity using Scheimpflug imaging. Management
Offer CXL treatment broadly without delaying based on age or ethnicity. Monitoring & Follow-up
Follow-up assessments at three years to evaluate corneal curvature and thickness. Risks
Corneal thinning postoperatively is expected; monitor for biomechanical effects. Patient & Prescribing Data
Patients with keratoconus from diverse ethnic backgrounds.
CXL is a reliable intervention regardless of demographic factors.
Clinical Best Practices
Stratify patients based on risk of progression for optimal treatment timing. Consider baseline severity as a primary factor in treatment planning. Related Resources & Content
